Can you provide a table of all FDA‑approved medications for bipolar disorder, including their indications, dosing specifications, and monitoring requirements?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FDA-Approved Medications for Bipolar Disorder

Below is a comprehensive table of all FDA-approved medications for bipolar disorder, organized by indication, with key specifications for clinical use. 1, 2

Table: FDA-Approved Bipolar Disorder Medications

Medication FDA Approval Acute Mania Bipolar Depression Maintenance Age Restriction Key Monitoring
Lithium ✓ ✓ — ✓ ≥12 years Serum levels (0.6-1.2 mEq/L), renal function (creatinine, eGFR), thyroid (TSH, T4), calcium, ECG baseline [1,3]
Valproate/Divalproex ✓ ✓ — — Adults only Liver function tests, CBC with platelets, ammonia if encephalopathy, serum levels (50-125 mcg/mL) [1,3]
Carbamazepine ✓ ✓ — ✓ Adults only CBC (risk of aplastic anemia/agranulocytosis), liver function, sodium, serum levels (4-12 mcg/mL), HLA-B*1502 in Asian ancestry [4]
Lamotrigine ✓ — — ✓ Adults only Skin monitoring (Stevens-Johnson syndrome risk, especially first 8 weeks), no routine labs required [1,2]
Aripiprazole ✓ ✓ — ✓ ≥10 years (mania) Weight, glucose, lipids, blood pressure, movement disorders (akathisia common) [1,2,3]
Aripiprazole LAI ✓ — — ✓ Adults only Same as oral aripiprazole, injection site reactions [2]
Asenapine ✓ ✓ — ✓ ≥10 years (mania) Weight, glucose, lipids, blood pressure, oral hypoesthesia (sublingual formulation) [2,3]
Cariprazine ✓ ✓ ✓ — Adults only Weight, glucose, lipids, blood pressure, movement disorders (akathisia) [2]
Lumateperone ✓ — ✓ — Adults only Weight, glucose, lipids, blood pressure [2]
Lurasidone ✓ — ✓ — ≥10 years (depression) Weight, glucose, lipids, blood pressure, akathisia, take with food (≥350 calories) [2,5,6]
Olanzapine ✓ ✓ — ✓ ≥13 years (mania) Weight (significant gain risk), glucose, lipids, blood pressure, prolactin [1,2,3]
Olanzapine + Fluoxetine ✓ — ✓ — ≥10 years Same as olanzapine plus serotonin syndrome monitoring [1,5,6]
Paliperidone ✓ ✓ — — Adults only Weight, glucose, lipids, blood pressure, prolactin, movement disorders, QTc prolongation [2,3]
Quetiapine ✓ ✓ ✓ ✓ ≥10 years (mania) Weight (significant gain risk), glucose, lipids, blood pressure, sedation, cataracts (baseline eye exam) [1,2,5,3]
Risperidone ✓ ✓ — — ≥10 years (mania) Weight, glucose, lipids, blood pressure, prolactin (significant elevation), movement disorders [1,2,3]
Risperidone LAI ✓ — — ✓ Adults only Same as oral risperidone, injection site reactions [2]
Ziprasidone ✓ ✓ — — Adults only QTc prolongation (baseline and follow-up ECG), electrolytes (K+, Mg2+), take with food (≥500 calories) [1,7,3]
Chlorpromazine ✓ ✓ — — Adults only Movement disorders, blood pressure (orthostasis), anticholinergic effects, rarely used first-line [1]

Critical Clinical Specifications

Acute Mania Treatment

  • First-line options: Lithium, valproate, aripiprazole, asenapine, cariprazine, olanzapine, quetiapine, risperidone 1, 2
  • Pediatric-approved (≥10-13 years): Aripiprazole, asenapine, olanzapine, quetiapine, risperidone 1, 2

Bipolar Depression Treatment

  • FDA-approved options: Cariprazine, lumateperone, lurasidone, olanzapine-fluoxetine, quetiapine 2, 5, 6
  • Pediatric-approved: Lurasidone (≥10 years), olanzapine-fluoxetine (≥10 years) 2
  • Critical caveat: Antidepressant monotherapy (without mood stabilizer) can precipitate mania and is NOT FDA-approved 1

Maintenance Treatment

  • FDA-approved: Aripiprazole (including LAI), asenapine, carbamazepine, lamotrigine, lithium, olanzapine, quetiapine, risperidone LAI 1, 2
  • Duration: Minimum 2 years after last episode, often lifelong 4

Monitoring Frequency 3

  • Baseline: All metabolic parameters (weight, glucose, lipids), renal/hepatic function, CBC, ECG (for specific agents)
  • Follow-up:
    • Weight: Monthly for first 3 months, then quarterly
    • Glucose/lipids: 3 months, then annually (more frequently with olanzapine/quetiapine)
    • Lithium levels: Weekly until stable, then every 3-6 months
    • Thyroid/renal (lithium): Every 6-12 months

Common Pitfalls to Avoid

  1. Lithium requires close monitoring - Cannot be initiated without laboratory monitoring capabilities; therapeutic window is narrow (0.6-1.2 mEq/L) 4, 1

  2. Metabolic syndrome risk - Olanzapine and quetiapine carry highest risk for weight gain and metabolic disruption; lurasidone is metabolically neutral 2, 5, 6

  3. Lamotrigine rash - Titrate slowly (25 mg/day for 2 weeks, then 50 mg/day for 2 weeks); faster titration or concurrent valproate increases Stevens-Johnson syndrome risk 1

  4. QTc prolongation - Ziprasidone requires ECG monitoring; avoid with other QTc-prolonging drugs or electrolyte abnormalities 7, 3

  5. Food requirements - Lurasidone requires ≥350 calories, ziprasidone requires ≥500 calories for adequate absorption 5, 3

  6. Pregnancy considerations - Valproate has highest teratogenicity risk (neural tube defects, cognitive impairment); avoid in women of childbearing potential when possible 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.